IRIS
PIRISI, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.631
EU - Europa 15.653
AS - Asia 9.615
SA - Sud America 1.577
Continente sconosciuto - Info sul continente non disponibili 754
AF - Africa 369
OC - Oceania 24
AN - Antartide 1
Totale 45.624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.906
RU - Federazione Russa 3.872
SG - Singapore 2.983
IE - Irlanda 2.775
IT - Italia 2.133
CN - Cina 1.986
DE - Germania 1.656
HK - Hong Kong 1.438
SE - Svezia 1.317
VN - Vietnam 1.311
FR - Francia 1.214
BR - Brasile 1.166
UA - Ucraina 947
IN - India 520
FI - Finlandia 492
GB - Regno Unito 479
CA - Canada 388
BD - Bangladesh 290
KR - Corea 252
AR - Argentina 163
ID - Indonesia 144
BJ - Benin 137
CZ - Repubblica Ceca 137
MX - Messico 122
PL - Polonia 121
TR - Turchia 109
AT - Austria 103
NL - Olanda 101
JP - Giappone 96
ZA - Sudafrica 90
ES - Italia 81
IQ - Iraq 79
IR - Iran 61
EC - Ecuador 54
PK - Pakistan 50
BE - Belgio 49
CL - Cile 45
CO - Colombia 44
VE - Venezuela 40
LT - Lituania 39
PH - Filippine 30
CR - Costa Rica 29
EG - Egitto 28
HN - Honduras 27
JM - Giamaica 27
PE - Perù 25
SA - Arabia Saudita 25
MA - Marocco 24
TH - Thailandia 24
TT - Trinidad e Tobago 24
PY - Paraguay 22
TW - Taiwan 22
AU - Australia 21
CH - Svizzera 21
MY - Malesia 21
EU - Europa 20
IL - Israele 19
GT - Guatemala 18
UZ - Uzbekistan 18
EE - Estonia 17
JO - Giordania 17
KE - Kenya 16
NP - Nepal 16
SV - El Salvador 16
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 15
PR - Porto Rico 15
RO - Romania 12
DK - Danimarca 11
PT - Portogallo 11
AL - Albania 10
DO - Repubblica Dominicana 10
GP - Guadalupe 10
KZ - Kazakistan 10
NG - Nigeria 10
AZ - Azerbaigian 9
NI - Nicaragua 9
UY - Uruguay 9
CW - ???statistics.table.value.countryCode.CW??? 8
LB - Libano 8
MD - Moldavia 8
OM - Oman 8
BB - Barbados 7
BH - Bahrain 7
RS - Serbia 7
SN - Senegal 7
BO - Bolivia 5
ET - Etiopia 5
GE - Georgia 5
LV - Lettonia 5
PS - Palestinian Territory 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
HR - Croazia 4
LK - Sri Lanka 4
MN - Mongolia 4
MO - Macao, regione amministrativa speciale della Cina 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
Totale 44.806
Salva come PNG Salva come JPEG
Città #
Dublin 2.756
San Jose 2.032
Jacksonville 1.666
Hong Kong 1.418
Singapore 1.118
Ashburn 1.068
Council Bluffs 1.058
Dearborn 729
Beijing 626
Chandler 603
Moscow 445
Los Angeles 443
Wilmington 434
Ho Chi Minh City 396
Columbus 380
Lauterbourg 359
Novara 343
Princeton 334
Lawrence 332
Hanoi 283
New York 272
San Mateo 251
Santa Clara 251
Buffalo 246
Ann Arbor 242
Munich 224
Piemonte 216
Phoenix 214
Milan 209
Seoul 207
São Paulo 154
Dallas 143
Cotonou 137
Houston 137
Orem 137
Andover 129
Turin 120
Frankfurt am Main 113
Boardman 112
Denver 103
Brooklyn 95
Warsaw 95
Montreal 93
Jakarta 91
Helsinki 90
Chennai 89
Nuremberg 85
Toronto 83
Chicago 82
London 75
Atlanta 73
Brno 73
Tokyo 73
Woodbridge 72
Vercelli 71
Philadelphia 69
Rome 67
Redondo Beach 66
Bremen 65
Guangzhou 64
Nanjing 62
Johannesburg 61
Poplar 61
Dong Ket 60
Falkenstein 60
Boston 58
Da Nang 55
Tianjin 53
Turku 53
Hefei 52
Mexico City 52
Stockholm 52
Amsterdam 47
Brussels 47
Seattle 47
Vienna 46
Haiphong 43
North Bergen 43
Mumbai 40
San Francisco 39
Schaumburg 39
Ankara 37
Düsseldorf 37
Norwalk 37
Shanghai 37
Hangzhou 36
Brasília 35
Manchester 34
Pardubice 34
Bologna 31
Kunming 29
Olathe 29
Rio de Janeiro 29
Biên Hòa 28
Hải Dương 27
Kocaeli 27
Paris 26
Baghdad 25
Hillsboro 25
Las Vegas 25
Totale 23.669
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 411
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 293
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
Genistein and 17β-Estradiol Protect Hepatocytes from Fatty Degeneration by Mechanisms Involving Mitochondria, Inflammasome and Kinases Activation 244
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 237
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 210
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 207
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 205
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 198
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 197
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 188
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 185
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 184
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 181
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 177
Change over time of COVID-19 hospital presentation in Northern Italy 175
Periodic clinical monitoring after liver transplantation 174
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 174
Testosterone Plasma Concentration is Associated with Insulin Resistance in Male Hypertensive Patients 174
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis 173
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 173
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 172
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 169
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 169
Vitamin D in Systemic Sclerosis: A Review 168
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 168
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 167
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 167
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 166
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 166
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 166
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 166
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 166
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 166
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 165
Is cholecalciferol a potential disease modifying anti-rheumatic drug for the management of rheumatoid arthritis? 164
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 163
Role of beta-blockers in patients with COPD: current perspective. 163
Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study. 163
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 163
Pattern of emergency department referral during the Covid-19 outbreak in Italy 163
Acute decompensated heart failure in the emergency department: Identification of early predictors of outcome 162
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 161
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 160
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 159
One-Year Follow up of Noninvasive Respiratory Support in General Wards 158
Higher Serum Monolaurin Is Associated with a Lower Risk of COVID-19: Results from a Prospective Observational Cohort Study 157
Association between rheumatic diseases and cancer: results from a clinical practice cohort study 157
Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis 157
"war to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients 154
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 152
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 152
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 152
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 152
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 152
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 151
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 149
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 148
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 148
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 146
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 146
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 145
A nurse-led coaching intervention with home telemonitoring for patients with heart failure: Protocol for a feasibility randomized clinical trial 144
4. Association between release of tumor necrosis factor and response to interferon therapy in chronic hepatitis C 144
First reported human case of meningitis by Staphylococcus condimenti 144
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 143
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 142
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 142
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 142
Eosinophilic gastroenteritis in pregnancy: A review of the literature 142
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 141
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 141
Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease 141
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 141
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 141
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 141
(Letter) Membranoproliferative glomerulonephritis associated with Hepatitis C infection with no evidence of liver disease 140
AORTIC INVOLVEMENT IN A RETROSPECTIVE COHORT OF LARGE VESSEL VASCULITIS PATIENTS 140
A 28-Year-Old Woman with Ascites and Multiple Focal Spleen Lesions 140
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 139
Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice 139
Understanding protection from SARS-CoV-2 using metabolomics 138
Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis 138
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 138
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 137
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 137
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 137
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 137
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 135
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 135
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 133
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 133
Modelling hospital bed necessity for COVID-19 patients during the decline phase of the epidemic trajectory 133
Diagnostic value of FibroTest with normal serum aminotransferases 132
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 132
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 131
Profiling the patients visiting the emergency room for musculoskeletal complaints: characteristics and outcomes 131
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 131
Influence of age on sex-related differences among patients with hepatitis C. 130
Totale 16.292
Salva come PNG Salva come JPEG
Categoria #
all - tutte 224.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.662 0 0 0 227 111 28 167 79 196 104 282 468
2022/20235.509 501 219 276 151 299 444 165 234 2.839 34 226 121
2023/20242.590 140 340 151 77 393 74 490 134 54 86 249 402
2024/20255.275 135 64 260 144 146 333 523 545 1.196 491 390 1.048
2025/202617.677 778 666 1.146 2.451 1.713 1.239 2.654 2.903 1.265 1.293 969 600
2026/20274.978 766 1.411 1.400 1.401 0 0 0 0 0 0 0 0
Totale 45.624